Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Take our poll: How does Breast Cancer Awareness Month make you feel?
Donate to Breastcancer.org when you checkout at Walgreens in October. Learn more about our Walgreens collaboration.

Clinical Trial for Metastatic TNBC Now Recruiting

WC3
WC3 Member Posts: 658
edited May 2022 in Clinical Trials, Research News, Podcasts, and Study Results

CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

Description

This phase I trial tests the safety, side effects, and best dose of CF33-hNIS-antiPDL1 in treating patients with triple negative breast cancer that has spread to other places in the body (metastatic). CF33-hNIS-antiPDL1 is an oncolytic virus. This is a virus that is designed to infect tumor cells and break them down.


Categories

Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.